173 related articles for article (PubMed ID: 9017686)
21. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
Yamaguchi Y; Katsumi N; Tauchi M; Toki M; Nakamura K; Aoki K; Morita Y; Miura M; Morozumi K; Ishida H; Takahashi S
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():111-5. PubMed ID: 15943857
[TBL] [Abstract][Full Text] [Related]
22. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
23. Gastric antiulcer activity of Syngonanthus arthrotrichus SILVEIRA.
Batista LM; de Almeida AB; de Pietro Magri L; Toma W; Calvo TR; Vilegas W; Souza Brito AR
Biol Pharm Bull; 2004 Mar; 27(3):328-32. PubMed ID: 14993797
[TBL] [Abstract][Full Text] [Related]
24. Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
Okai T; Sawabu N; Songür Y; Motoo Y; Watanabe H
J Clin Gastroenterol; 1995; 20 Suppl 2():S32-5. PubMed ID: 7594335
[TBL] [Abstract][Full Text] [Related]
25. Gastroprotective activity of the novel proton pump inhibitor lansoprazole in the rat.
Morini G; Grandi D; Arcari ML; Bertaccini G
Gen Pharmacol; 1995 Sep; 26(5):1021-5. PubMed ID: 7557244
[TBL] [Abstract][Full Text] [Related]
26. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
27. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion.
Blum RA; Shi H; Karol MD; Greski-Rose PA; Hunt RH
Clin Ther; 1997; 19(5):1013-23. PubMed ID: 9385488
[TBL] [Abstract][Full Text] [Related]
28. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA
Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
[TBL] [Abstract][Full Text] [Related]
29. In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity.
Arnestad JS; Kleveland PM; Waldum HL
Aliment Pharmacol Ther; 1997 Apr; 11(2):355-8. PubMed ID: 9146775
[TBL] [Abstract][Full Text] [Related]
30. Age-dependent eradication of Helicobacter pylori with dual therapy.
Treiber G; Ammon S; Klotz U
Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
[TBL] [Abstract][Full Text] [Related]
31. Effects of lansoprazole on mucosal regeneration in patients with gastric ulcers: evaluation using an electronic endoscope with a magnifying function.
Hashimoto M; Hoshihara Y; Yamamoto T; Tanaka T; Kimura T; Iguchi D; Sugawara K; Fukuchi S; Takemoto T
J Clin Gastroenterol; 1995; 20 Suppl 2():S59-61. PubMed ID: 7594343
[TBL] [Abstract][Full Text] [Related]
32. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
34. Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice.
Bilic I; Zoricic I; Anic T; Separovic J; Stancic-Rokotov D; Mikus D; Buljat G; Ivankovic D; Aralica G; Prkacin I; Perovic D; Mise S; Rotkvic I; Petek M; Rucman R; Seiwerth S; Sikiric P
Life Sci; 2001 Mar; 68(16):1905-12. PubMed ID: 11292068
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
[TBL] [Abstract][Full Text] [Related] 
